CM Griffith, T Eid, GM Rose, PR Patrylo - Neuropharmacology, 2018 - Elsevier
Epidemiological data have shown that metabolic disease can increase the propensity for
developing cognitive decline and dementia, particularly Alzheimer's disease (AD). While this …